![Matt DeLisa, David Putnam, and Gary Whittaker in the lab](/sites/default/files/styles/width_270/public/content/news/image/news_Universal-flu-vaccine-developed-at-Cornell-nearing-human-trials_chronicle.png?itok=wM9E8mQy)
Universal flu vaccine developed at Cornell nearing human trials
A universal influenza vaccine developed with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases. Read more